問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberMK-7240-001
Active

2024-02-01 - 2032-12-31

Phase III

Not yet recruiting1

Recruiting4

ICD-10K51.90

Ulcerative colitis, unspecified, without complications

ICD-10K51.911

Ulcerative colitis, unspecified with rectal bleeding

ICD-10K51.912

Ulcerative colitis, unspecified with intestinal obstruction

ICD-10K51.913

Ulcerative colitis, unspecified with fistula

ICD-10K51.914

Ulcerative colitis, unspecified with abscess

ICD-10K51.918

Ulcerative colitis, unspecified with other complication

ICD-10K51.919

Ulcerative colitis, unspecified with unspecified complications

ICD-9556.9

Ulcerative colitis, unspecified

  • Trial Applicant

    Merck Sharp & Dohme (I.A.) LLC

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/02/01

Investigators and Locations

Principal Investigator Puo-Hsien Le

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator SHU-CHEN WEI

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 翁孟慈

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 顏旭亨

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Tsung-Yu Tsai

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    20 participants

  • Global

    1020 participants